-
1
-
-
0023205811
-
The cell biology of multiple drug resistance
-
Beck WT. The cell biology of multiple drug resistance. Biochem Pharmacol. 1987;36:2879-2887.
-
(1987)
Biochem Pharmacol
, vol.36
, pp. 2879-2887
-
-
Beck, W.T.1
-
4
-
-
0036364467
-
Multidrug resistance in cancer: Role of ATP-dependent transporters
-
Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2:48-58.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 48-58
-
-
Gottesman, M.M.1
Fojo, T.2
Bates, S.E.3
-
5
-
-
0022972654
-
Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells
-
Chen C-J, Chin JE, Ueda K, et al. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 1986;47:381-389.
-
(1986)
Cell
, vol.47
, pp. 381-389
-
-
Chen, C.-J.1
Chin, J.E.2
Ueda, K.3
-
6
-
-
0008632564
-
Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin, and vinblastine
-
Ueda K, Cardarelli C, Gottesman MM, Pastan I. Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA. 1987;84:3004-3008.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 3004-3008
-
-
Ueda, K.1
Cardarelli, C.2
Gottesman, M.M.3
Pastan, I.4
-
7
-
-
0027095653
-
Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
-
Cole SP, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 1992;258:1650-1654.
-
(1992)
Science
, vol.258
, pp. 1650-1654
-
-
Cole, S.P.1
Bhardwaj, G.2
Gerlach, J.H.3
-
8
-
-
0027960078
-
Pharmacological characterization of multidrug resistant MRP-transfered human tumor cells
-
Cole SP, Sparkes KE, Fraser K, et al. Pharmacological characterization of multidrug resistant MRP-transfered human tumor cells. Cancer Res. 1994;54:5902-5910.
-
(1994)
Cancer Res
, vol.54
, pp. 5902-5910
-
-
Cole, S.P.1
Sparkes, K.E.2
Fraser, K.3
-
9
-
-
13044249156
-
A multidrug resistance transporter from human MCF-7 breast cancer cells
-
Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Sci USA. 1998;95:15665-15670.
-
(1998)
Proc Natl Sci USA
, vol.95
, pp. 15665-15670
-
-
Doyle, L.A.1
Yang, W.2
Abruzzo, L.V.3
-
10
-
-
0032895533
-
Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes
-
Miyake K, Mickey L, Litman T, et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 1999;59:8-13.
-
(1999)
Cancer Res
, vol.59
, pp. 8-13
-
-
Miyake, K.1
Mickey, L.2
Litman, T.3
-
11
-
-
0034728768
-
The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane
-
Rocchi E, Khodjakov A, Volk EL, et al. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane. Biochem Biophys Res Commun. 2000;271:42-46.
-
(2000)
Biochem Biophys Res Commun
, vol.271
, pp. 42-46
-
-
Rocchi, E.1
Khodjakov, A.2
Volk, E.L.3
-
12
-
-
18744421466
-
Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines
-
Scheffer GL, Maliepaard M, Pijnenborg ACLM, et al. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines. Cancer Res. 2000;60:2589-2593.
-
(2000)
Cancer Res
, vol.60
, pp. 2589-2593
-
-
Scheffer, G.L.1
Maliepaard, M.2
Pijnenborg, A.C.L.M.3
-
13
-
-
0033568540
-
Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line
-
Maliepaard M, van Gastelen MA, de Jong LA, et al. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res. 1999;59:4559-4563.
-
(1999)
Cancer Res
, vol.59
, pp. 4559-4563
-
-
Maliepaard, M.1
van Gastelen, M.A.2
de Jong, L.A.3
-
14
-
-
0034666736
-
-
Yang CH, Schneider E, Kuo ML, Volk EL, Rocchi E, Chen YC. BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells. Biochem Pharmacol. 2000; 60:831-837.
-
Yang CH, Schneider E, Kuo ML, Volk EL, Rocchi E, Chen YC. BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells. Biochem Pharmacol. 2000; 60:831-837.
-
-
-
-
15
-
-
0034817098
-
Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells
-
Kawabata S, Oka M, Shiozawa K, et al. Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem Biophys Res Commun. 2001;280:1216-1223.
-
(2001)
Biochem Biophys Res Commun
, vol.280
, pp. 1216-1223
-
-
Kawabata, S.1
Oka, M.2
Shiozawa, K.3
-
16
-
-
0036732010
-
Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance
-
Volk EL, Farley KM, Wu Y, Li F, Robey RW, Schneider E. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res. 2002; 62:5035-5040.
-
(2002)
Cancer Res
, vol.62
, pp. 5035-5040
-
-
Volk, E.L.1
Farley, K.M.2
Wu, Y.3
Li, F.4
Robey, R.W.5
Schneider, E.6
-
17
-
-
0345688604
-
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
-
Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene. 2003;22:7340-7358.
-
(2003)
Oncogene
, vol.22
, pp. 7340-7358
-
-
Doyle, L.A.1
Ross, D.D.2
-
18
-
-
0029126403
-
DNA methylation in early development
-
Razin A, Shemer R. DNA methylation in early development. Hum Mol Genet. 1995;4:1751-1755.
-
(1995)
Hum Mol Genet
, vol.4
, pp. 1751-1755
-
-
Razin, A.1
Shemer, R.2
-
19
-
-
0034176798
-
DNA hypermethylation in tumorigenesis
-
Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis. Trends Genet. 2000;16:168-174.
-
(2000)
Trends Genet
, vol.16
, pp. 168-174
-
-
Baylin, S.B.1
Herman, J.G.2
-
20
-
-
0036274359
-
The fundamental role of epigenetic events in cancer
-
Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415-428.
-
(2002)
Nat Rev Genet
, vol.3
, pp. 415-428
-
-
Jones, P.A.1
Baylin, S.B.2
-
21
-
-
0345357773
-
Gene silencing in cancer in association with promoter hypermethylation
-
Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003; 349:2042-2054.
-
(2003)
N Engl J Med
, vol.349
, pp. 2042-2054
-
-
Herman, J.G.1
Baylin, S.B.2
-
22
-
-
0030722392
-
Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance
-
Kantharidis P, El-Osta A, deSilva M, et al. Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance. Clin Cancer Res. 1997;3: 2025-2032.
-
(1997)
Clin Cancer Res
, vol.3
, pp. 2025-2032
-
-
Kantharidis, P.1
El-Osta, A.2
deSilva, M.3
-
23
-
-
0032403478
-
Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias
-
Nakayama M, Wada M, Harada T, et al. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Blood. 1998;92:4296-4307.
-
(1998)
Blood
, vol.92
, pp. 4296-4307
-
-
Nakayama, M.1
Wada, M.2
Harada, T.3
-
24
-
-
0034351878
-
MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment
-
Tada Y, Wada M, Kuroiwa K, et al. MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment. Clin Cancer Res. 2000;6:4618-4627.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 4618-4627
-
-
Tada, Y.1
Wada, M.2
Kuroiwa, K.3
-
25
-
-
8444224421
-
MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: Changes in chromatin structure induced by treatment with 5-aza-cytidine
-
David GL, Yegnasubramanian S, Kumar A, et al. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-aza-cytidine. Cancer Biol Ther. 2004;3:540-548.
-
(2004)
Cancer Biol Ther
, vol.3
, pp. 540-548
-
-
David, G.L.1
Yegnasubramanian, S.2
Kumar, A.3
-
26
-
-
28544432478
-
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs
-
Baker EK, Johnstone RW, Zalcberg JR, El-Osta A. Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs. Oncogene. 2005;24:8061-8075.
-
(2005)
Oncogene
, vol.24
, pp. 8061-8075
-
-
Baker, E.K.1
Johnstone, R.W.2
Zalcberg, J.R.3
El-Osta, A.4
-
27
-
-
0030785681
-
DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant
-
Joto N, Ishii M, Minami M, Kuga H, Mitsui I, Tohgo A. DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant. Int J Cancer. 1997;72:680-686.
-
(1997)
Int J Cancer
, vol.72
, pp. 680-686
-
-
Joto, N.1
Ishii, M.2
Minami, M.3
Kuga, H.4
Mitsui, I.5
Tohgo, A.6
-
28
-
-
12444261717
-
Expression and functional analyses of breast cancer resistance protein in lung cancer
-
Kawabata S, Oka M, Soda H, et al. Expression and functional analyses of breast cancer resistance protein in lung cancer. Clin Cancer Res. 2003;9:3052-3057.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 3052-3057
-
-
Kawabata, S.1
Oka, M.2
Soda, H.3
-
29
-
-
0035884595
-
Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP- overexpressing cells
-
Honjo Y, Hrycyna CA, Yan Q-W, et al. Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP- overexpressing cells. Cancer Res. 2001; 61:6635-6639.
-
(2001)
Cancer Res
, vol.61
, pp. 6635-6639
-
-
Honjo, Y.1
Hrycyna, C.A.2
Yan, Q.-W.3
-
30
-
-
12444263205
-
Mutation and quantitative analysis of breast cancer resistance protein (BCRP/MXR/ABCG2) gene in lung cancer cells [abstract]
-
Nakatomi K, Oka M, Shiozawa K, et al. Mutation and quantitative analysis of breast cancer resistance protein (BCRP/MXR/ABCG2) gene in lung cancer cells [abstract]. Proc Am Assoc Cancer Res. 2002;43:778.
-
(2002)
Proc Am Assoc Cancer Res
, vol.43
, pp. 778
-
-
Nakatomi, K.1
Oka, M.2
Shiozawa, K.3
-
31
-
-
0036598543
-
C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance
-
Imai Y, Nakane M, Kage K, et al. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol Cancer Ther. 2002;1:611-616.
-
(2002)
Mol Cancer Ther
, vol.1
, pp. 611-616
-
-
Imai, Y.1
Nakane, M.2
Kage, K.3
-
32
-
-
0037073730
-
Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation
-
Ozvegy C, Varadi A, Sarkadi B. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation. J Biol Chem. 2002; 277:47980-47990.
-
(2002)
J Biol Chem
, vol.277
, pp. 47980-47990
-
-
Ozvegy, C.1
Varadi, A.2
Sarkadi, B.3
-
33
-
-
10744232004
-
Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic
-
Shiozawa K, Oka M, Soda H, et al. Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic. Int J Cancer. 2004;108:146-151.
-
(2004)
Int J Cancer
, vol.108
, pp. 146-151
-
-
Shiozawa, K.1
Oka, M.2
Soda, H.3
-
34
-
-
0035929437
-
Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene
-
Bailey-Dell KJ, Hassel B, Doyle LA, Ross DD. Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim Biophys Acta. 2001; 1520:234-241.
-
(2001)
Biochim Biophys Acta
, vol.1520
, pp. 234-241
-
-
Bailey-Dell, K.J.1
Hassel, B.2
Doyle, L.A.3
Ross, D.D.4
-
35
-
-
0029843950
-
Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
-
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996;93:9821-9826.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 9821-9826
-
-
Herman, J.G.1
Graff, J.R.2
Myohanen, S.3
Nelkin, B.D.4
Baylin, S.B.5
-
36
-
-
0031434813
-
Role of estrogen receptor gene demethylation and DNA methyltransferase-DNA adduct formation in 5-aza-2′ deoxycytidine-induced cytotoxicity in human breast cancer cells
-
Ferguson AT, Vertino PM, Spizner JR, Baylin SB, Muller MT, Davidson NE. Role of estrogen receptor gene demethylation and DNA methyltransferase-DNA adduct formation in 5-aza-2′ deoxycytidine-induced cytotoxicity in human breast cancer cells. J Biol Chem. 1997;272:32260-32266.
-
(1997)
J Biol Chem
, vol.272
, pp. 32260-32266
-
-
Ferguson, A.T.1
Vertino, P.M.2
Spizner, J.R.3
Baylin, S.B.4
Muller, M.T.5
Davidson, N.E.6
-
37
-
-
33845261204
-
ABCG2 expression, function, and promoter methylation in human multiple myeloma
-
Turner JG, Gump JL, Zhang C, et al. ABCG2 expression, function, and promoter methylation in human multiple myeloma. Blood. 2006;108:3881-3889.
-
(2006)
Blood
, vol.108
, pp. 3881-3889
-
-
Turner, J.G.1
Gump, J.L.2
Zhang, C.3
-
38
-
-
33751017087
-
Aberrant promoter methylation of the ABCG2 gene in renal carcinoma
-
To KK, Zhan Z, Bates SE. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma. Mol Cell Biol. 2006;26:8572-8585.
-
(2006)
Mol Cell Biol
, vol.26
, pp. 8572-8585
-
-
To, K.K.1
Zhan, Z.2
Bates, S.E.3
-
39
-
-
33744944548
-
Novel 5′ untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: Implications for drug resistance, tissue-specific expression, and alternative promoter usage
-
Nakanishi T, Bailey-Dell KJ, Hassel BA, et al. Novel 5′ untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage. Cancer Res. 2006;66:5007-5011.
-
(2006)
Cancer Res
, vol.66
, pp. 5007-5011
-
-
Nakanishi, T.1
Bailey-Dell, K.J.2
Hassel, B.A.3
-
41
-
-
0035324425
-
5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer
-
Zochbauer-Muller S, Fong KM, Maitra A, et al. 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res. 2001;61:3581-3585.
-
(2001)
Cancer Res
, vol.61
, pp. 3581-3585
-
-
Zochbauer-Muller, S.1
Fong, K.M.2
Maitra, A.3
-
42
-
-
0037130885
-
Inactivation of BRCA1 and BRCA2 in ovarian cancer
-
Hilton JL, Geisler JP, Rathe JA, Hattermann-Zogg MA, DeYoung B, Buller RE. Inactivation of BRCA1 and BRCA2 in ovarian cancer. J Natl Cancer Inst. 2002;94:1396-1406.
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 1396-1406
-
-
Hilton, J.L.1
Geisler, J.P.2
Rathe, J.A.3
Hattermann-Zogg, M.A.4
DeYoung, B.5
Buller, R.E.6
-
43
-
-
0142188174
-
Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation
-
Padar A, Sathyanarayana UG, Suzuki M, et al. Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation. Clin Cancer Res. 2003;9:4730-4734.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 4730-4734
-
-
Padar, A.1
Sathyanarayana, U.G.2
Suzuki, M.3
-
44
-
-
29744431723
-
Promoter methylation and inactivation of tumour-suppressor genes in oral squamous cell carcinoma
-
Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous cell carcinoma. Lancet Oncol. 2006;7:77-82.
-
(2006)
Lancet Oncol
, vol.7
, pp. 77-82
-
-
Ha, P.K.1
Califano, J.A.2
|